The 10-year drug strategy for England and Wales was published in February 2008. It dropped drugs-related deaths (DRDs) as a key performance indicator. Scotland retained a necessary strong focus on DRDs. Scotland's DRDs numbered 1,006 in 2000-02 and 1,009 in 2003-05. The previous Scottish administration's claim that its number of current injectors had decreased substantially between 2000 and 2003 implied, paradoxically, that their DRD rate would have to have increased. Worse was to come: Scotland's DRDs had increased to 876 in 2006+2007. We analyse UK's DRDs by sex and age-group to reveal temporal trends (2000-02 versus 2003-05 versus 2006+2007) with different public health and epidemiological implications. We also address the above Scottish paradox and assess, by age-group, how consistent Scotland's 876 DRDs in 2006+07 are with Scottish injectors' DRD rate in 2003-05 of around 1 per 100 injector-years. Public health success in the UK in reducing DRDs at younger ages should not be overshadowed by the late consequence (older-age DRDs) of UK's injector epidemics: in the early 1980s in Scotland, and late 1980s in England and Wales. Targets for reducing DRDs should pay heed to UK's injector epidemics. [188 words]
Introduction
A new drug strategy for England and Wales (2008-18) was published in February 2008 (HM Government, 2008) . Drugs-related deaths (DRDs) were dropped as a key performance indicator, perhaps because the previous target -to reduce DRDs by 20% between 1999 and 2004 -had been missed (Morgan et al., 2006; Report, 2007) . Only a 9% reduction could be claimed (Morgan et al., 2006) when DRDs were defined in accordance with recommendations by the Advisory Council on the Misuse of Drugs (2000) (ACMD).
Scotland's new drugs strategy, Road to Recovery, was published in May 2008 (The Scottish Government, 2008a) . In the wake of Scotland's confidential inquiry into DRDs in 2003 (Zador et al., 2005) Most DRDs are opiate-related, and they mostly occur in injecting drug users (IDUs). We therefore delve deeper -firstly, to analyse by age-group because the epidemic history of injection drug use in the UK requires it (Bird et al., 2003) and, secondly, to address a Scottish paradox about injectors' DRD rate having apparently increased in 2003-05.
By analysing within age-group (Bird et al., 2003) , we show, first, that the above 3-year totals obscure public health success, in terms of very significant reductions in UK's DRDs at younger ages. However, we also reveal the late epidemiological consequence of UK's national epidemics of injecting drug use in the 1980s. Morgan et al. (2008) recently, and rightly, called for a better international understanding of the mechanisms that underlie overdose mortality statistics than mere age-standardisation to a common 5 European population allows (Morgan et al., 2006) . Age-standardisation masks, rather than reveals, trends which are importantly different by age.
The differences by age that we reveal have their origin in the epidemic nature of injecting drug use. The number of current IDUs was estimated to have increased 6-fold in Scotland between 1980-89 (Hutchinson et al., 2006) . The corresponding increase in England was at The Scottish paradox arose as follows. Because DRDs are mainly opiate-related and occur mostly in IDUs, there is reason to estimate DRDs rates per 100 current IDUs (Bird et al., 2003) , a relevant denominator, as recommended by ACMD (2000) . Capturerecapture estimates of Scotland's current IDUs in 2000 (see Hay et al., 2001; King et al., 2005; Bird et al., 2003) and again in 2003 King et al., 2008) were publicly reported (Scottish Government News Release, 2005) as suggesting that the prevalent number of IDUs had decreased from 25,000 in 2000 to nearer 19,000 by 2003. To address this Scottish paradox, we here set Scotland's markedly increased DRDs in 2006+2007 against the backdrop of previously-published, credibly-estimated DRD rates, by sex and age-group, for Scottish injectors in 2003-05 (King et al., 2008) . The rates were derived from a Bayesian capture-recapture approach to estimating the number of Scotland's current IDUs in 2003, which had given a higher central estimate of around 26,000 IDUs (King et al., 2008) .
Our Approach
Scotland's DRDs in 2000-02 and 2003-05 are summarised in eight pre-defined (Bird et al., 2003; King et al., 2005) subgroups (sex by age-group by region) as in our Scottish work hitherto. Thus, prior to Bird et al. (2003) , the age-group (15-34 years; 35+ years) and regional subdivisions (Greater Glasgow; elsewhere in Scotland) were specifically selected on the basis of knowledge of Scotland's IDU epidemic. They have been used by us since then to demonstrate that, as anticipated by Scotland's IDU epidemic history, Scottish DRD trends are markedly different, notably by age-group.
We summarise DRDs registered in England and Wales without taking cognizance of regional IDU epidemics and only according to publicly-available age-groups (under 30 years, 30-39 years, 40+ years), see Report (2008) . We do so to check for a similar downward trend in DRDs for the youngest age-group.
Next, corresponding national data for the two years, 2006+2007, are presented; and compared to age-specific expectations from 2003-05.
Finally, we exploit results from our published Bayesian capture-recapture analysis of Scotland's data-sources on IDUs in 2003 (King et al., 2008) King et al. (2008) for more detail, or Appendix for a precis. Table 3 reproduces 
Analysis addressing three questions

Does Scotland's historical injector epidemic determine its age-related increase in DRDs?
Discussion
Major sources of uncertainty hinder a full understanding of injectors' DRD rates, namely:
which DRDs actually pertain to IDUs, toxicology (whether opiate-related or not; and copresence of other drugs), and how influential the demographic factors of sex, older age and region actually are on DRD rates (Bird et al., 2003; Morgan et al., 2008; King et al., 2005; Bargagli et al., 2006) .
For England and Wales, as well as for Scotland, there was good news in 2000-05. Public health measures were beginning to make a difference by reducing DRDs at younger ages -to an even greater extent in the under 30s in England and Wales than in Scotland's under 35s (χ 2 = 5.18, p ~ 0.02).
However, the UK's target to reduce DRDs by 20% between 1999 and 2004 took no apparent cognizance (Bargagli et al., 2006; Bird et al., 2005) of the (different) epidemiology of injecting drug use in Scotland (Hutchinson et al., 2006) Table 1 ). Of course, competing age-related trends within the 30-39 year old age-group (for decrease; for increase) could potentially cancel each other out.
No forward projections have been made from UK's IDU epidemics in the 1980s to the likely numbers of DRDs among older IDUs in the 21 st century for either Scotland or England and Wales. There is therefore no reference-projection against which to compare, for example, Scotland's 410 older DRDs in 2006+2007. Are they more numerous, or fewer, than would have been plausibly projected from Scotland's historical IDU epidemic? We don't know. Age-group specific projections for injector-related DRDs in England and Wales over the next five years would be a boon.
Apparently higher DRD rates in 2006+2007 for Scotland's IDUs, as in Table 3 , could be due to our having used -as the only available denominator -Scotland's estimated numbers of older IDUs in 2003 King et al., 2008) (Report, 2008) did not mirror the rise in Scotland. Any genuine rise in DRDs at younger ages has a range of interpretations, all of them disquieting. They include: i) increase in prevalence of younger current IDUs, ii) more risky injecting patterns by younger IDUs, iii) differential purity in the available heroin to which less experienced IDUs may be most vulnerable, iv) changed predisposition to DRDs by young people's more risky coincident use of other drugs including alcohol, or v) lower referral rate for drugs rehabilitation.
Public health scientists have tended to follow the trail of DRDs (Morgan et al., 2008) rather than anticipate their trajectory by making projections, as is done for the sequelae of other injection-related epidemics such as hepatitis C virus .
Ideally, targets on DRDs should be epidemiologically-informed by plausible forward projections. The absence of such projections may explain the UK governments' reluctance to set revised DRD targets (HM Government, 2007; The Scottish Government, 2008) for 2008-18. Separate recognition is now needed of older-age opiate-related DRDs as a late consequence of the UK's historical IDU epidemics, the timing of which differed between (and also within) Scotland and England and Wales. More nuanced analyses of DRDs are therefore needed, which take account of their demography and toxicology simultaneously, rather than severally (Report, 2008) .
We urge that public health success in the UK at reducing younger-age DRDs, which are a consequence (mainly) of heroin injection, should be neither overlooked nor made hostage to fortune by disproportionate focus on rarely-lethal drugs such as cannabis (Advisory Council on the Misuse of Drugs, 2008). By contrast, the lethal harm from injecting heroin is stark, well-quantified, and well-attributed: let young lives be not lost by their, or our, ignorance (Surveys, Design and Statistics Subcommittee, 2008 
